Hella Kohlhof
Executive Officer at Immunic.
Raised on Immunic filings
$200M
of $200M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 13
- Last filing
- Mar 4, 2026
Company
Oral drugs for multiple sclerosis and colitis
- Investors
- 43
Immunic filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Mar 4, 2026 | Equity | $200M/ $200M | Form D |
- EquityFiled Mar 4, 2026Form D$200M/ $200M
Works with
Daniel VittChief Executive Officer, Form D signerForm D signerJason TardioExecutive OfficerAndreas MuehlerExecutive OfficerBarclay PhillipsDirectorDuane NashDirectorGlenn WhaleyExecutive OfficerInderpal SinghExecutive OfficerJoerg NeermanDirectorPatrick WalshExecutive OfficerRichard RudickDirectorSimona SkerjanecDirectorTamar HowsonDirectorThorvald NagelDirector
